244 related articles for article (PubMed ID: 3084343)
1. There is more to healing ulcers than suppressing acid.
Colin-Jones DG
Gut; 1986 May; 27(5):475-80. PubMed ID: 3084343
[No Abstract] [Full Text] [Related]
2. Newer drugs in the treatment of peptic ulcer.
Tandon BN
Trop Gastroenterol; 1985; 6(4):188-92. PubMed ID: 3913076
[No Abstract] [Full Text] [Related]
3. Use of cytoprotective agents in the treatment of gastric ulcers.
Lam SK
Med J Aust; 1985 Feb; 142 Spec No():S21-3. PubMed ID: 3841578
[No Abstract] [Full Text] [Related]
4. [Sucralfate protects the ulcer from acids and pepsin].
von Bocko Polach U
Med Klin; 1980 Oct; 75(21):764-7. PubMed ID: 6779100
[No Abstract] [Full Text] [Related]
5. [Innovations in the treatment of gastroduodenal ulcers].
Bernier JJ
Presse Med; 1983 May; 12(21):1355-8. PubMed ID: 6304676
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
7. Sucralfate for peptic ulcer--a reappraisal.
Med Lett Drugs Ther; 1984 Apr; 26(660):43-4. PubMed ID: 6323938
[No Abstract] [Full Text] [Related]
8. [Selective and locally-acting drugs in the treatment of peptic ulcer].
Ryss ES
Klin Med (Mosk); 1984 Jul; 62(7):10-8. PubMed ID: 6384654
[No Abstract] [Full Text] [Related]
9. [Progress in the pharmacotherapy of peptic ulcer].
Stasiewicz J; Moniuszko-Jakoniuk J
Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1721-5. PubMed ID: 6151657
[No Abstract] [Full Text] [Related]
10. Inhibition of peptic aggression by sucralfate. The view from the ulcer crater.
Samloff IM
Scand J Gastroenterol Suppl; 1983; 83():7-11. PubMed ID: 6415806
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic approach to ulcer healing.
Blum AL
Am J Med; 1985 Aug; 79(2C):8-14. PubMed ID: 2863981
[TBL] [Abstract][Full Text] [Related]
12. Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol).
Baron JH; Barr J; Batten J; Sidebotham R; Spencer J
Gut; 1986 May; 27(5):486-90. PubMed ID: 3084345
[TBL] [Abstract][Full Text] [Related]
13. Colloidal bismuth subcitrate in peptic ulcer disease.
Tytgat GN
S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
[TBL] [Abstract][Full Text] [Related]
14. [Effective drugs and less effective drugs in the treatment of duodenal ulcer].
Ligny G; Van Cauter J
Acta Gastroenterol Belg; 1984; 47(6):569-75. PubMed ID: 6100349
[No Abstract] [Full Text] [Related]
15. Present and future treatment of peptic ulcer and potential role of DE-NOL.
Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
[No Abstract] [Full Text] [Related]
16. Sucralfate, bismuth compounds, substituted benzimidazoles, trimipramine and pirenzepine in the short- and long-term treatment of duodenal ulcer.
Tytgat GN; Hameeteman W; van Olffen GH
Clin Gastroenterol; 1984 May; 13(2):543-68. PubMed ID: 6378446
[No Abstract] [Full Text] [Related]
17. [Ulcer healing without acid inhibition].
Koelz HR
Dtsch Med Wochenschr; 1985 May; 110(20):806-9. PubMed ID: 2859974
[No Abstract] [Full Text] [Related]
18. Update in treatment of peptic ulcer disease.
Schubert TT
Mo Med; 1984 Nov; 81(11):723-7. PubMed ID: 6095013
[No Abstract] [Full Text] [Related]
19. Use of cytoprotective agents in the treatment of gastric ulcers.
Lam SK
Med J Aust; 1985 Feb; 142(3):S21-3. PubMed ID: 3881652
[No Abstract] [Full Text] [Related]
20. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
May B
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
